TY - JOUR
T1 - Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors
AU - Al-Zaid, Tariq
AU - Ditelberg, Jeremy S.
AU - Prieto, Victor G.
AU - Lev, Dina
AU - Luthra, Raja
AU - Davies, Michael A.
AU - Diwan, A. Hafeez
AU - Wang, Wei Lien
AU - Lazar, Alexander J.
PY - 2012/5
Y1 - 2012/5
N2 - Background: Trichilemmoma (TL) can occur as a solitary sporadic lesion usually on the face or as multiple facial lesions almost invariably associated with Cowden syndrome (CS). CS is a multisystem disorder caused by a germline inactivating mutation in PTEN (10q23.31), a tumor suppressor gene. We sought to identify PTEN loss by immunohistochemistry (IHC) in sporadic and CS-associated TL to determine whether IHC is a useful tool to assess an individual for CS. Methods: Six TL biopsies associated with CS and 33 biopsies without CS were retrieved. IHC for PTEN was performed. Results were scored as positive (reactivity in TL cells) or negative (no reactivity in TL cells); normal squamous epithelium and vascular endothelium served as internal positive controls. Results: Complete PTEN loss was noted in 5/6 (83%) CS-associated TL and 1/33 (3%) sporadic (non-CS) TL. Conclusion: Demonstration of complete PTEN loss in TL by IHC is strongly suggestive of association with CS, but retention of PTEN staining does not entirely exclude CS. Therefore, PTEN IHC in TLs may be helpful in screening TL for association with CS, but should be used in context with other established clinical criteria, and possibly germline PTEN genotyping to confirm a diagnosis of CS. Al-Zaid T, Ditelberg JS, Prieto VG, Lev D, Luthra R, Davies MA, Diwan AH, Wang W-L, Lazar AJ. Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors.
AB - Background: Trichilemmoma (TL) can occur as a solitary sporadic lesion usually on the face or as multiple facial lesions almost invariably associated with Cowden syndrome (CS). CS is a multisystem disorder caused by a germline inactivating mutation in PTEN (10q23.31), a tumor suppressor gene. We sought to identify PTEN loss by immunohistochemistry (IHC) in sporadic and CS-associated TL to determine whether IHC is a useful tool to assess an individual for CS. Methods: Six TL biopsies associated with CS and 33 biopsies without CS were retrieved. IHC for PTEN was performed. Results were scored as positive (reactivity in TL cells) or negative (no reactivity in TL cells); normal squamous epithelium and vascular endothelium served as internal positive controls. Results: Complete PTEN loss was noted in 5/6 (83%) CS-associated TL and 1/33 (3%) sporadic (non-CS) TL. Conclusion: Demonstration of complete PTEN loss in TL by IHC is strongly suggestive of association with CS, but retention of PTEN staining does not entirely exclude CS. Therefore, PTEN IHC in TLs may be helpful in screening TL for association with CS, but should be used in context with other established clinical criteria, and possibly germline PTEN genotyping to confirm a diagnosis of CS. Al-Zaid T, Ditelberg JS, Prieto VG, Lev D, Luthra R, Davies MA, Diwan AH, Wang W-L, Lazar AJ. Trichilemmomas show loss of PTEN in Cowden syndrome but only rarely in sporadic tumors.
KW - Cowden syndrome
KW - PTEN
KW - immunohistochemistry
KW - trichilemmoma
UR - http://www.scopus.com/inward/record.url?scp=84860217787&partnerID=8YFLogxK
U2 - 10.1111/j.1600-0560.2012.01888.x
DO - 10.1111/j.1600-0560.2012.01888.x
M3 - ???researchoutput.researchoutputtypes.contributiontojournal.article???
C2 - 22486434
AN - SCOPUS:84860217787
SN - 0303-6987
VL - 39
SP - 493
EP - 499
JO - Journal of Cutaneous Pathology
JF - Journal of Cutaneous Pathology
IS - 5
ER -